Antithrombotic Strategies to Reduce Adverse Clinical Outcomes in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Antithrombotic Strategies to Reduce Adverse Clinical Outcomes in Patients With Acute Coronary Syndrome

Published:2012-10 Issue:8 Volume:110 Page:1200-1206
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Brieger David

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Heart disease and stroke statistics—2011 update: a report from the American Heart Association;Roger;Circulation,2011

2. Burden of disease: medical and economic impact of acute coronary syndromes;Turpie;Am J Manag Care,2006

3. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Rosamond;Circulation,2008

4. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

5. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation;Smith;Circulation,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life;Patient Education and Counseling;2021-08

2. All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study;Vascular Health and Risk Management;2018-11

3. Guideline-adherent therapy in patients with acute coronary syndromes;Herz;2014-11-07

4. Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes;Circulation Research;2014-06-06

5. Investigation of the antiangiogenic behaviors of rivaroxaban and low molecular weight heparins;Blood Coagulation & Fibrinolysis;2014-06